Ledidi hosted the final Propel summer gathering to connect alumni and innovators.

The Ledidi platform is designed for MedTech, biotech, pharma, and research teams generate and own high-quality clinical evidence — without the cost, complexity, or dependency of traditional models. Our secure, compliant platform supports the full evidence lifecycle, bringing feasibility studies, registries, clinical trials, post-market surveillance, and real-world evidence together in one workspace. Evidence is more than a requirement; it’s a strategic asset that benefits from long-term ownership. Built for the people running the studies, Ledidi removes the need for developers or heavy IT involvement, enabling faster setup, lower overhead, and greater flexibility as clinical strategies evolve. Ledidi Core enables teams to design studies themselves, capture structured clinical data, collaborate in real time, and generate insights through built-in analytics and visualisation — all while maintaining full control over data access, privacy, and governance. Ledidi Trials extends the platform with GCP E6(R3) and FDA 21 CFR Part 11–compliant clinical trial functionality for regulatory-grade trials and interventional studies, helping teams design and activate trials faster and more affordably. One platform. Full evidence ownership. Affordable. Compliant. Adaptable.